News Fulcrum Therapeutics promises new drugs for rare disorders Company launched following $55 million series A funding round.
News Agenovir secures funding for CRISPR antiviral therapies Antiviral therapy specialist Agenovir has secured $10.6 million in funding from a series A funding round.
News Caribou gains $30m funding for CRISPR-Cas platform Genetic engineering specialist Caribou Biosciences has secured $30 million in a series B funding round.
News We’re No.1 in CRISPR gene-editing race, says AstraZeneca The technology known as CRISPR/Cas9 has been described as the 'holy grail' of genetic engineering, and has become the hottest research area because of its potential to cure many diseases by
News DNA testing can help right racial imbalance in breast cancer Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
